October 14 (Hfrance.fr) - Walgreens Boots Alliance Inc 's (WBA.O) Fourth quarter results exceed estimates for increased drugstore sales in US and UK due to the easing of restrictions related to the pandemic and people infected with COVID -19 vaccines in its stores.
The company has administered more than 40 million COVID-19 vaccines and more than 16 million tests to date, he said.
Same-store sales of its U.S. drugstores grew 8.8% in the fourth quarter, including a 485 basis point increase in COVID-19 vaccinations, the company said.e. Walgreens filled 313 million preions during the quarter.
Shares of the Deerfield, Illinois, based company one of the largest drugstores in the United States, rose 1.6% to $ 48 pre-market. .
Net income attributable to the company was $ 627 million, or 72 cents per share, for the quarter ended Aug. 31, compared with earnings of $ 373 million, or 43 cents per share, a year earlier.
Excluding items, the company earned $ 1.17 per share, against Refinitiv IBES 'estimate of $ 1.02 per share.
Revenue reached $ 34.26 billion from $ 30.37 billion, while analysts estimated an average of $ 33.30 billion. Report by Dania Nadeem and Leroy Leo in Bangalore; Edited by Vinay Dwivedi
Our standards: Thomson Hfrance's principles of trust. en.